98 related articles for article (PubMed ID: 8943758)
1. Granulocyte-colony stimulating factor concentrations in a patient with plasma cell dyscrasia and clinical features of chronic neutrophilic leukaemia.
Nagai M; Oda S; Iwamoto M; Marumoto K; Fujita M; Takahara J
J Clin Pathol; 1996 Oct; 49(10):858-60. PubMed ID: 8943758
[TBL] [Abstract][Full Text] [Related]
2. [Granulocyte-colony stimulating factor-producing myeloma with clinical manifestations mimicking chronic neutrophilic leukemia].
Kusaba N; Yoshida H; Ohkubo F; Mishima K; Shimamastu K; Okamura T; Sata M
Rinsho Ketsueki; 2004 Mar; 45(3):228-32. PubMed ID: 15103937
[TBL] [Abstract][Full Text] [Related]
3. Production of granulocyte colony-stimulating factor and granulocyte/macrophage-colony-stimulating factor after interleukin-1 stimulation of marrow stromal cell cultures from normal or aplastic anemia donors.
Migliaccio AR; Migliaccio G; Adamson JW; Torok-Storb B
J Cell Physiol; 1992 Jul; 152(1):199-206. PubMed ID: 1377699
[TBL] [Abstract][Full Text] [Related]
4. Granulocyte colony-stimulating factor, granulocyte macrophage colony-stimulating factor and neutrophils in the bronchoalveolar lavage fluid of premature infants with respiratory distress syndrome.
Papoff P; Christensen RD; Calhoun DA; Juul SE
Biol Neonate; 2001 Aug; 80(2):133-41. PubMed ID: 11509813
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor in treated patients with chronic myelogenous leukemia in chronic phase.
Balleari E; Bason C; Visani G; Gobbi M; Ottaviani E; Ghio R
Haematologica; 1994; 79(1):7-12. PubMed ID: 15378942
[TBL] [Abstract][Full Text] [Related]
6. [Granulocyte-colony stimulating factor-producing multiple myeloma presenting with neutrophilia].
Yokoi M; Kondo T; Shimizu R; Uchida K; Hayashi S; Nishimura H; Kondo E; Wada H
Rinsho Ketsueki; 2023; 64(8):735-740. PubMed ID: 37673624
[TBL] [Abstract][Full Text] [Related]
7. Preclinical and clinical studies of bone marrow uptake of fluorine-1-fluorodeoxyglucose with or without granulocyte colony-stimulating factor during chemotherapy.
Sugawara Y; Fisher SJ; Zasadny KR; Kison PV; Baker LH; Wahl RL
J Clin Oncol; 1998 Jan; 16(1):173-80. PubMed ID: 9440740
[TBL] [Abstract][Full Text] [Related]
8. Neutrophilia associated with anaplastic carcinoma of the thyroid: production of macrophage colony-stimulating factor (M-CSF) and interleukin-6.
Sato T; Omura M; Saito J; Hirasawa A; Kakuta Y; Wakabayashi Y; Nishikawa T
Thyroid; 2000 Dec; 10(12):1113-8. PubMed ID: 11201858
[TBL] [Abstract][Full Text] [Related]
9. [A case of chronic neutrophilic leukemia accompanied with severe bone marrow fibrosis which was effectively treated by hydroxyurea].
Hirayama Y; Koda K; Matsumoto S; Takayanagi M; Ezoe A; Nobuoka A; Nakazawa O
Rinsho Ketsueki; 1994 Nov; 35(11):1329-34. PubMed ID: 7823400
[TBL] [Abstract][Full Text] [Related]
10. Hematologic effects of recombinant murine granulocyte-macrophage colony-stimulating factor on the peripheral blood and bone marrow.
Ulich TR; del Castillo J; McNiece I; Watson L; Yin SM; Andresen J
Am J Pathol; 1990 Aug; 137(2):369-76. PubMed ID: 1696784
[TBL] [Abstract][Full Text] [Related]
11. G-CSF and GM-CSF concentrations and receptor expression in peripheral blood leukemic cells from patients with chronic myelogenous leukemia.
Lee J; Kim Y; Lim J; Kim M; Han K
Ann Clin Lab Sci; 2008; 38(4):331-7. PubMed ID: 18988925
[TBL] [Abstract][Full Text] [Related]
12. Decreased production of cytokines after cytomegalovirus infection of marrow-derived stromal cells.
Lagneaux L; Delforge A; Snoeck R; Stryckmans P; Bron D
Exp Hematol; 1994 Jan; 22(1):26-30. PubMed ID: 7506672
[TBL] [Abstract][Full Text] [Related]
13. The hematologic effects of chronic administration of the monokines tumor necrosis factor, interleukin-1, and granulocyte-colony stimulating factor on bone marrow and circulation.
Ulich TR; del Castillo J; Guo K; Souza L
Am J Pathol; 1989 Jan; 134(1):149-59. PubMed ID: 2464282
[TBL] [Abstract][Full Text] [Related]
14. Granulocyte Colony-stimulating Factor Producing Anaplastic Carcinoma of the Pancreas: Case Report and Review of the Literature.
Vinzens S; Zindel J; Zweifel M; Rau T; Gloor B; Wochner A
Anticancer Res; 2017 Jan; 37(1):223-228. PubMed ID: 28011495
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological study of involvement of granulocyte colony stimulating factor and granulocyte-macrophage colony stimulating factor in non-lymphohematopoietic malignant tumors accompanied by leukocytosis.
Kojima K; Nakashima F; Boku A; Muroishi Y; Nakanishi I; Oda Y
Histol Histopathol; 2002 Oct; 17(4):1005-16. PubMed ID: 12371127
[TBL] [Abstract][Full Text] [Related]
16. Treatment with granulocyte colony-stimulating factor increases interleukin-1 receptor antagonist levels during engraftment following allogeneic stem-cell transplantation.
Schwabe M; Hartert AM; Bertz H; Finke J
Eur J Clin Invest; 2004 Nov; 34(11):759-65. PubMed ID: 15530149
[TBL] [Abstract][Full Text] [Related]
17. The detection of colony-stimulating factors and steel factor in adherent layers of human long-term marrow cultures using reverse-transcriptase polymerase chain reaction.
Deschaseaux ML; Hervé P; Charbord P
Leukemia; 1994 Mar; 8(3):513-9. PubMed ID: 7510357
[TBL] [Abstract][Full Text] [Related]
18. Increased granulocyte-colony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF) levels in BAL fluid from patients with sulfur mustard gas-induced pulmonary fibrosis.
Emad A; Emad Y
J Aerosol Med; 2007; 20(3):352-60. PubMed ID: 17894541
[TBL] [Abstract][Full Text] [Related]
19. A high-fat diet increases interleukin-3 and granulocyte colony-stimulating factor production by bone marrow cells and triggers bone marrow hyperplasia and neutrophilia in Wistar rats.
do Carmo LS; Rogero MM; Paredes-Gamero EJ; Nogueira-Pedro A; Xavier JG; Cortez M; Borges MC; Fujii TM; Borelli P; Fock RA
Exp Biol Med (Maywood); 2013 Apr; 238(4):375-84. PubMed ID: 23760003
[TBL] [Abstract][Full Text] [Related]
20. G-CSF is a major component of colony-stimulating activity (CSA) in the plasma of patients with multiple myeloma after treatment with high-dose melphalan (HDM).
Joffe JK; Bell JB; Denham S; Adshead F; Millar JL; Millar BC
Exp Hematol; 1995 Apr; 23(4):376-82. PubMed ID: 7534716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
